In 2024, the U.S. Drug Enforcement Administration (DEA) indicated they intend to reclassify cannabis as a Schedule III drug. This rescheduling will identify that cannabis has genuine clinical applications and will help open the door to analysis on other probable procedure employs.When taken recreationally, cannabis, is most commonly taken While usi